Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: Findings from the International Consortium of Bladder Cancer

Cancer Research

Volumn 69, Issue 17, 2009, Pages 6857-6864

  Stern, Mariana C ^a   Lin, Jie ^c   Figueroa, Jonine D ^d   Kelsey, Karl T ^e   Kiltie, Anne E ^f   Yuan, Jian Min ^h   Matullo, Giuseppe ^i,j   Fletcher, Tony ^k   Benhamou, Simone ^m,n   Taylor, Jack A ^o   Placidi, Donatella ^p   Zhang, Zuo Feng ^b   Steineck, Gunnar ^q,r   Rothman, Nathaniel ^d   Kogevinas, Manolis ^s,t,u,v   Silverman, Debra ^d   Malats, Nuria ^w   Chanock, Stephen ^d   Wu, Xifeng ^c   Karagas, Margaret R ^x   Andrew, Angeline S ^x   Nelson, Heather H ^x   Bishop, D Timothy ^g   Sei, Chung Sak ^f   Choudhury, Ananya ^f   Barrett, Jennifer H ^g   Elliot, Faye ^g   Corral, Román ^a   Joshi, Amit D ^a   Gago Dominguez, Manuela ^a   Cortessis, Victoria K ^a   Xiang, Yong Bing ^y   Gao, Yu Tang ^y   Vineis, Paolo ^i,l   Sacerdote, Carlotta ^j   Guarrera, Simonetta ⁱ   Polidoro, Silvia ⁱ   Allione, Alessandra ⁱ   Gurzau, Eugen ^z   Koppova, Kvetoslava ^aa   Kumar, Rajiv ^ab   Rudnai, Peter ^ac   Porru, Stefano ^p   Carta, Angela ^p   Campagna, Marcello ^p   Arici, Cecilia ^p   Park, Sung Shim Lani ^b   Garcia Closas, Montserrat ^d   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ ISI FOUNDATION   (Italy)

^j UNIVERSITY OF TURIN   (Italy)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m INSERM   (France)

ⁿ CNRS   (France)

^o NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^p UNIVERSITY OF BRESCIA   (Italy)

^q KAROLINSKA INSTITUTE   (Sweden)

^r UNIVERSITY OF GOTHENBURG   (Sweden)

^s CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^t INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v UNIVERSITY OF CRETE   (Greece)

^w Centro Nacional de Investigaciones Oncológicas   (Spain)

^x DARTMOUTH MEDICAL SCHOOL   (United States)

^y SHANGHAI CANCER INSTITUTE   (China)

^z Environmental Health Center   (Romania)

^aa State Health Institute   (Slovakia)

^ab GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ac NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA REPAIR; GENE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NBN GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CONTINENTAL POPULATION GROUPS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 70149111066     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1091     Document Type: Article

References (49)

1. Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol.38. Lyon: IARC; 1986.
2. Scelo G, Brennan P. The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 2007;4:205-217
3. Vineis P, Talaska G, Malaveille C, et al. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer 1996;65:314-316 (Pubitemid 26059985)
4. Turesky RJ, Freeman JP, Holland RD, et al. Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol 2003;16:1162-1173
5. Pryor WA, Hales BJ, Premovic PI, Church DF. The radicals in cigarette tar: their nature and suggested physiological implications. Science 1983;220:425-427
6. Maeda H, Sawa T, Yubisui T, Akaike T. Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. Cancer Lett 1999;143:117-121 (Pubitemid 29392942)
7. Burger MS, Torino JL, Swaminathan S. DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl. Environ Mol Mutagen 2001;38:1-11. (Pubitemid 32762091)
8. Siraki AG, Chan TS, Galati G, Teng S, O'Brien PJ. Noxidation of aromatic amines by intracellular oxidases. Drug Metab Rev 2002;34:549-564 (Pubitemid 35012001)
9. Miller KP, Ramos KS. Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab Rev 2001;33:1-35.
10. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-659
11. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008;299:2423-2436 (Pubitemid 351749241)
12. Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1832-1836 (Pubitemid 40995103)
13. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990;6:5-30. (Pubitemid 20287159)
14. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442 (Pubitemid 38443646)
15. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst 2004;96:421-423
16. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: design and analysis issues. Mutat Res 2005;573:54-69. (Pubitemid 40501972)
17. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144:207-213
18. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005;26:1263-1271 (Pubitemid 41417904)
19. Fontana L, Bosviel R, Delort L, et al. DNA repair gene E RCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 2008;28:1853-1856 (Pubitemid 351892896)
20. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:2537-2541 (Pubitemid 46048318)
21. Friedberg EC, Walker GC, Siede W. DNA repair and mutagenesis. 2nd ed.Washington (DC): ASM Press; 2006.
22. Gillet LC, Scharer OD. Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem Rev 2006;106:253-276 (Pubitemid 43316557)
23. D'Errico M, Parlanti E, Teson M, et al. New functions of XPC in the protection of human skin cells from oxidative damage. Embo J 2006;25:4305-4315 (Pubitemid 44435228)
24. Melis JP, Wijnhoven SW, Beems RB, et al. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res 2008;68:1347-1353
25. Laczmanska I, Gil J, Karpinski P, et al. Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations. Environ Mol Mutagen 2007;48:666-671 (Pubitemid 350006275)
26. Seker H, Butkiewicz D, Bowman ED, et al. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer research 2001;61:7430-7434 (Pubitemid 32995030)
27. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGEreview. American journal of epidemiology 2005;161:1-14. (Pubitemid 40053274)
28. Vineis P, Manuguerra M, Kavvoura FK, et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009;101:24-36.
29. Riches LC, Lynch AM, Gooderham NJ. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 2008;23:331-339
30. Ryk C, Routledge MN, Allan JM, et al. Influence of DNA repair gene polymorphisms on the initial repair of MMS-induced DNA damage in human lymphocytes as measured by the alkaline comet assay. Environ Mol Mutagen 2008;49:669-675
31. Musak L, Soucek P, Vodickova L, et al. Chromosomal aberrations in tire plant workers and interaction with polymorphisms of biotransformation and DNA repair genes. Mutat Res 2008;641:36-42.
32. Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 2003;12:1234-1240 (Pubitemid 37499450)
33. Covolo L, Placidi D, Gelatti U, et al. Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a casecontrol study. Eur J Epidemiol 2008;23:355-362
34. Thirumaran RK, Bermejo JL, Rudnai P, et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006;27:1676-1681 (Pubitemid 44288057)
35. Wu X, Lin J, Grossman HB, et al. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 2007;25:4974-4981 (Pubitemid 350220430)
36. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006;78:464-479 (Pubitemid 43291228)
37. Castelao JE, Yuan JM, Skipper PL, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-545 (Pubitemid 32318433)
38. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet 2007;8:13.
39. Choudhury A, Elliott F, Iles MM, et al. Analysis of variants in DNA damage signalling genes in bladder cancer. BMC Med Genet 2008;9:69.
40. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 2005;92:2262-2265
41. Bell DA, Taylor JA, Butler MA, et al. Genotype/ phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993;14:1689-1692
42. Stern MC, Johnson LR, Bell DA, Taylor JA. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1004-1011
43. Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:939-943
44. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-131 (Pubitemid 32172431)
45. Andrew AS, Karagas MR, Nelson HH, et al. DNA repair polymorphisms modify bladder cancer risk: a multifactor analytic strategy. Hum Hered 2008;65:105-118
46. Andrew AS, Nelson HH, Kelsey KT, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006;27:1030-1037
47. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-734 (Pubitemid 38618524)
48. Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 2005;14:2569-2578 (Pubitemid 41752717)
49. Cao W, Cai L, Rao JY, et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 2005;104:2400-2408